Concepedia

Sarah L. Mott

SL

Statistics

Publications

75

Citations

3K

H-Index

30

Active since

1992

Affiliations

University of Iowa(Current)

University of Iowa Hospitals and Clinics

University of Iowa Holden Comprehensive Cancer Center

University of Minnesota

The University of Texas MD Anderson Cancer Center

Sarah L. Mott is an author at University of Iowa specializing in medicine, oncology, and chemotherapy.

ORCID

Publications per year

1992–2024

75

Publications

75

Sarcopenia is an independent predictor of complications following pancreatectomy for adenocarcinoma

S. Joglekar, Aeen Asghar, Sarah L. Mott et al. · Journal of Surgical Oncology · 2014 · 274 citations · Full text

, , +17

Indications for and outcome of total abdominal hysterectomy for benign disease: a prospective cohort study

Aileen Clarke, Nick Black, Pam Rowe et al. · BJOG An International Journal of Obstetrics & Gynaecology · 1995 · 215 citations

, , +11

Multi-Institution Evaluation of Sequential Gemcitabine and Docetaxel as Rescue Therapy for Nonmuscle Invasive Bladder Cancer

Ryan L. Steinberg, Lewis J. Thomas, Nathan A. Brooks et al. · The Journal of Urology · 2019 · 182 citations

, , +5

Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer

Ian M. McElree, Ryan L. Steinberg, Sarah L. Mott et al. · JAMA Network Open · 2023 · 113 citations · Full text

, , +9

Pharmacological Ascorbate Radiosensitizes Pancreatic Cancer

Juan Du, John A. Cieslak, Jessemae L. Welsh et al. · Cancer Research · 2015 · 111 citations

, , +17

1–5 of 75